High-sensitivity Troponin in the Evaluation of patients with Acute Coronary Syndrome (HighSTEACS): A randomised controlled trial The aim is to determine whether lowering the diagnostic threshold for myocardial infarction using a novel high-sensitivity cardiac troponin assay will improve outcomes in patients with suspected acute coronary syndrome. Chief Investigator: Prof Nicholas Mills Number and location of participating sites (by region/ country): 10 sites across NHS Lothian and NHS Greater Glasgow & Clyde, Scotland ClinicalTrials.gov Identifier NCT01852123 http://clinicaltrials.gov/ct2/show/NCT01852123 Funder: British Heart Foundation Start and End date of grant award: October 2012 – October 2017 Current Status: Completed and Published at https://doi.org/10.1016/S0140-6736(18)31923-8 Protocol: Document HighSTEACS protocol document (1.54 MB / 0_16MAY2018) Statistical Analysis Plan: Document ECTU HighSTEACS Statistical Analysis Plan (229.94 KB / 0) UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document. Document ECTU HighSTEACS GDPR privacy statement (749.89 KB / PDF) Contact details Sponsor: University of Edinburgh, NHS Lothian Health Board ACCORD Chief Investigator: Professor Nicholas Mills, Room SU225, Chancellor's Building, University of Edinburgh, Royal Infirmary, Little France, Edinburgh, EH16 4SB, UK Clinical Research Manager: Fiona Strachan ECTU Involvement : Trial management / Statistics/ Database (UKCRC) Image This article was published on 2024-09-24
